Dermatology · Sacramento, CA
NPI
1043250145
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5601 J St
Sacramento, CA, 95819
Phone (916) 454-5922
Groups this clinician bills Medicare through
Medicare paid, 2024
$593K
10,177 services
Medicare patients, 2024
1,616
Average age 77
Drug cost, 2024
$1.6M
1,767 prescriptions
Company payments, 2025
$152K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emil A Tanghetti was code 17003 (destruction skin lesion), 2,704 times for 591 patients. In total Emil A Tanghetti billed 10,177 services in 80 codes, and Medicare paid $593K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,704 | 591 | $5.93 | $16K |
| 99213 Office E&M - Established | Office | 2,579 | 1,425 | $69.30 | $179K |
| 17000 Destruction Skin Lesion | Office | 1,142 | 792 | $41.99 | $48K |
| 11102 Skin Biopsy | Office | 761 | 640 | $72.39 | $55K |
| 17110 Destruction Skin Lesion | Office | 413 | 353 | $93.33 | $39K |
| 99212 Office E&M - Established | Office | 394 | 277 | $48.82 | $19K |
| 11103 Skin Biopsy | Office | 354 | 230 | $43.99 | $16K |
| 99214 Office E&M - Established | Office | 151 | 127 | $102.91 | $16K |
| 99203 Office E&M - New | Office | 139 | 139 | $68.41 | $9,509 |
| 11104 Skin Biopsy | Office | 124 | 116 | $101.92 | $13K |
| 12032 Wound Repair - All Levels | Office | 118 | 104 | $265.35 | $31K |
| 17263 Destruction Skin Lesion | Office | 75 | 61 | $160.91 | $12K |
| 11602 Skin Lesion Excision | Office | 75 | 60 | $116.69 | $8,752 |
| 10060 Skin | Office | 71 | 69 | $113.08 | $8,029 |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 65 | 52 | $286.94 | $19K |
By year: 2022 $467K for 10,495 services; 2023 $581K for 11,943 services; 2024 $593K for 10,177 services.
Medicare prescription drug claims, 2024
In 2024, the drug Emil A Tanghetti prescribed most often to Medicare patients was Doxycycline Monohydrate, with 220 prescriptions and refills. In total Emil A Tanghetti wrote 1,767 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Monohydrate Generic | 220 | 276 | 101 | $3,367 |
| Ketoconazole Generic | 175 | 193 | 117 | $4,983 |
| Fluorouracil Generic | 150 | 152 | 140 | $9,767 |
| Clobetasol Propionate Generic | 141 | 157 | 105 | $7,908 |
| Hydrocortisone Generic | 130 | 134 | 119 | $481 |
| Metronidazole Generic | 107 | 127 | 67 | $5,090 |
| Econazole Nitrate Generic | 95 | 111 | 61 | $3,150 |
| Triamcinolone Acetonide Generic | 87 | 118 | 59 | $1,202 |
| Mometasone Furoate Generic | 79 | 79 | 67 | $1,186 |
| Doxycycline Hyclate Generic | 54 | 54 | 26 | $2,182 |
| Cephalexin Generic | 37 | 37 | 32 | $556 |
| Acyclovir Generic | 33 | 49 | 18 | $363 |
| Skyrizi Pen Risankizumab-Rzaa | 32 | 88 | Under 11 | $670K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 31 | 36 | Under 11 | $273K |
| Clindamycin Phos-Benzoyl Perox Clindamycin Phos/Benzoyl Perox | 29 | 29 | 22 | $810 |
Brand drugs: 215 claims; generic drugs: 1,552 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emil A Tanghetti $152K ($152K in general payments such as food, travel and fees) from 21 companies. The largest payer was UCB, Inc. with $40K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 44 | $40K |
| Arcutis Biotherapeutics, Inc. ARQT | 24 | $22K |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 14 | $21K |
| Botanix SB Inc | 22 | $19K |
| Galderma Laboratories, L.P. GALD.SW | 13 | $16K |
| Organon LLC OGN | 11 | $14K |
| Abbvie Inc. ABBV | 26 | $11K |
| Incyte Corporation INCY | 40 | $7,751 |
| Kowa Pharmaceuticals America, Inc. | 1 | $750 |
| Genzyme Corporation SNY | 9 | $308 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.